Tails from the Peak District: adjusted censored mixture models of EQ-5D health state utility values by Hernández Alava, M. et al.
 - 1 - 
 
 
 
 
 
 
HEDS Discussion Paper 10/08 
 
 
 
Disclaimer: 
This is a Discussion Paper produced and published by the Health Economics 
and Decision Science (HEDS) Section at the School of Health and Related 
Research (ScHARR), University of Sheffield.  HEDS Discussion Papers are 
intended to provide information and encourage discussion on a topic in 
advance of formal publication.  They represent only the views of the authors, 
and do not necessarily reflect the views or approval of the sponsors. 
 
White Rose Repository URL for this paper: 
http://eprints.whiterose.ac.uk/11074/ 
 
Once a version of Discussion Paper content is published in a peer-reviewed 
journal, this typically supersedes the Discussion Paper and readers are invited 
to cite the published version in preference to the original version. 
 
Published paper 
None. 
 
White Rose Research Online 
eprints@whiterose.ac.uk 
 
 
 
 
 
 
 
 
 - 2 - 
 
 
 
Tails from the Peak District: Adjusted Censored
Mixture Models of EQ-5D Health State Utility
Values
Mónica Hernández Alava, Allan J. Wailoo, Roberta Ara
Health Economics & Decision Science,
School of Health and Related Research, University of She¢ eld
July 2010
ABSTRACT: Health state utility data generated using the EQ-5D instrument are
typically right bounded at one with a substantial gap to the next set of observations,
left bounded by some negative value, and are multi modal. These features present
challenges to the estimation of the e¤ect of clinical and socioeconomic characteristics
on health utilities. We present an adjusted censored model and then use this in
a exible, mixture modelling framework to address these issues. We demonstrate
superior performance of this model compared to linear regression and Tobit censored
regression using a dataset from repeated observations of patients with rheumatoid
arthritis. We nd that three latent classes are appropriate in estimating EQ-5D
from function, pain and sociodemographic factors. Analysis of utility data should
apply methods that recognise the distributional features of the data.
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1 Introduction
The Quality Adjusted Life Year (QALY) has become one of the most widely used
outcome measures in economic evaluations. The QALY is useful to healthcare deci-
sion makers seeking to apply a consistent approach across a broad range of disease
areas, treatments and patients and is required by several international bodies, such
as the National Institute for Health and Clinical Excellence (NICE) in England and
Wales (NICE (2008)). Typically, QALYs are generated from patient completion of
a survey instrument that provides a generic description of health in terms of symp-
toms and impact on functioning, to which standardised, preference based scoring
systems can then be applied. Instruments such as the EQ-5D, SF6D and Health
Utilities Index (HUI) are in widespread use. Other approaches to generating QALYs
include the use of disease specic instruments which have similar preference based
scoring systems or direct valuation of health states by patients themselves. It is well
documented that the use of di¤erent approaches or instruments results in di¤erent
estimates of health state utilities, and therefore, ultimately, di¤erent estimates of
cost e¤ectiveness and decisions. As a consequence, some decision makers express
a clear preference for the use of a particular approach. In England and Wales for
example, NICE recommends the EQ-5D (NICE (2008)).
Clinical studies, and in particular randomised controlled trials, used to estimate
the treatment e¤ect of a health technology often do not include any preference based
outcome measures. Furthermore, even where such outcomes are included, they may
not be relevant to the setting for the economic evaluation. There may therefore be
a gap between the data available from the clinical studies and the requirements of
the economic evaluation.
In some situations it may be possible to bridge this gap by estimating the rela-
tionship between a clinical measure(s) and a preference based measure where both
have been included in an external dataset. This then provides a statistical link
between the treatment e¤ect observed in the clinical studies using clinical outcome
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measures and a preference based measure that can be used to estimate QALYs in
the economic evaluation. The tting of a statistical model for this purpose has
been referred to in previous literature as mappingor crosswalking, borrowing
terminology from psychometrics. There are other situations where one may wish to
t a statistical model to health utility data, for example to explore the impact of
socioeconomic factors or treatments directly.
A recent review of 30 studies (Brazier et al. (2009)) indicates that the statistical
models used tend to be relatively simplistic. Simple linear models dominate, with
limited use of Tobit or similar models for dealing with censored data. However,
health state utility data tend to exhibit features which may call for more exible
statistical models. In addition to upper bounding at full health (1), utility data are
also left bounded at the worst imaginable health state, have gaps between values
and tend to have distinct bi or tri-modal distributions. Furthermore, both clinical
trials and observational studies typically include multiple observations from each
individual. Statistical models used to estimate health state utilities ought to reect
these data characteristics in order to avoid biased estimates. This is now well recog-
nised in relation to health related costs where the use of generalized linear multilevel
(sometimes called random e¤ects or hierarchical) models have been discussed to deal
with left boundedness, skewness and the clustered nature of the data (Hernández
Alava and Wailoo (2010), Thompson et al. (2006)).
In this paper we develop an adjusted censored regression to address the right
censoring and the gap between full health and intermediate health states that is a
feature of EQ-5D. We then develop exible, random e¤ects mixture (or latent class)
models to account for the other key features of the distribution of EQ-5D values.
Section 2 provides a detailed account of the statistical issues to be addressed and
outlines how these have been considered in the literature to date. Then in section
3 we describe the data and methods. This rst covers a description of an example
dataset from a trial of patients with rheumatoid arthritis (RA) and then describes
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the statistical models to be applied. Results are provided in section 4. Section 5
provides a discussion of the results and the implications of the models estimated
here.
2 Background
2.1 The typical distribution of EQ-5D
The EQ-5D questionnaire asks respondents to describe their health in ve domains
(mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of
which can be at one of three severity levels (no problems/some or moderate prob-
lems/extreme problems). 243 combinations can be described in this way. A score
can be assigned to each of these states based on analysis of preference data ob-
tained from approximately 3,000 members of the general public in the UK Dolan et
al. (1995).
Figure 1 displays the distribution of health state utilities derived using UK pref-
erence weights for the widely used EQ-5D instrument from 11 studies in di¤erent
clinical areas. Several features should be noted. First, there is often a mass of ob-
servations at 1, full health, which is the maximum value feasible for health utility.
There is then a relatively large gap before the next observations which begin at
0.883. 0.883 is the highest utility score that can be generated using the UK regres-
sion model for scoring EQ-5D reported by Dolan et al. (1995) and applies to the
health state 11211, that is, where the patient indicates that the only reduction from
full health is by having "some problems" with their usual activities. The score of
1, that is, full health, is not capable of being generated by the Dolan model. Thus,
there is no connection between the value for full health and the values for all other
health states accounting for this rst large gap in observed EQ-5D scores.
Second, for each of the examples, the distribution of values are bi or tri-modal
with each of the separate components of the distribution centred around 0.7 and
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0.2 approximately. Their precise location, the degree of kurtosis and skew in each
of these components varies according to the specic setting and, in particular, the
severity of the condition. The lower section of the distribution is a consequence
of the "N3" term in the scoring model which assigns a large utility decrement to
any health state that includes extreme problems in any dimension. Furthermore,
these characteristics are not limited to health utilities generated via the UK EQ-
5D scoring model. The US scoring of EQ-5D for example also demonstrates a
large gap between full health and the next set of values at 0.86, Shaw et al. (2005)
and apparently separate components of the distribution below this level. Huang et
al. (2008) presents a histogram of US EQ-5D valuations from patients with HIV that
demonstrates this gap as well as the multi modal characteristic of the distribution.
The process of building a statistical model which uses EQ-5D as the dependent
variable should recognise these features in order to avoid biased estimates.
2.2 Existing literature
Brazier et al. (2009) identied 30 studies which examine the relationship between
health outcome measures that are not preference based and generic preference-based
measures. Of these, half used the EQ-5D as the dependent variable, with variants of
the Health Utilities Index (HUI) in 8 studies and SF-6D in 5 studies. AQoL, QWB
and 15D were included in the remainder with some studies including more than one
measure.
The authors of the review reported that the vast majority of the included stud-
ies tted straightforward linear models. There was very limited use of censored
regression models or any attempt to deal with the non normal characteristics of the
distribution of values. Typically scant attention is paid to model diagnostics. The
R2 statistic was seen to dominate model selection in these studies, notwithstanding
the fact that R2 cannot be used to compare models with di¤erent dependent vari-
5
Figure 1: Distribution of EQ-5D from 11 studies in di¤erent clinical areas
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ables and a raft of other criticisms of this approach that are well documented in the
econometrics literature, see for example Charemza and Deadman (1992).
Several other authors have considered the use of Tobit and other censored re-
gression models for dealing with the bounded nature of health utility data. These
studies were not included in the Brazier et al. (2009) review because they do not at-
tempt to model the relationship between health preference data and other outcome
measures but are instead interested in the impact of the determinants of health or
socioeconomic factors. Austin et al. (2000) conducted a simulation study to com-
pare linear regression models to Tobit censored models and found Tobit performed
better in the presence of censoring. Austin (2002) also compared linear regression
with the Tobit model and variants of the Tobit: the symmetrically trimmed least
squares and censored least absolute deviations (CLAD) models using data on the
HUI from a large Canadian population health survey. Huang et al. (2008) found
that the CLAD model performed poorly in a study using the EQ-5D (US scores) as
the dependent variable based on data from HIV infected patients. They reported
consistently better performance from latent class models and two-part models where
a log transformation is used in the second part. The focus of this study was solely on
methods to address the mass of observations at one and for this reason they include
only two latent classes. However, it is unclear that a two class model is capable of
overcoming this challenge unless either the underlying distribution for the classes is
itself suitable for censored data or if one class has a zero variance in which case the
model is equivalent to the two part model. Similarly, Li and Fu (2009) applied a
two part model to US EQ-5D data. Specically they explored how the second part
of the model, for those individuals that do not score one, may be approached in a
number of ways.
Pullenayegum et al. (2010) compared the performance of Tobit, CLAD, linear re-
gression, twopart and latent class models when modelling data that are constrained
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by one. As with Huang et al. (2008), only two latent classes were included, both
with normal distributions. They reported that both Tobit and CLAD models yield
biased estimates when the variable of interest is not able to exceed one rather than
simply being censored by the measurement instrument at one. Linear regression,
latent class model and the two part estimators were reported as unbiased.
No studies have developed methods to deal with the numerous challenges that
are presented by the distribution of EQ-5D data. Of particular note is that the use
of latent class models has been limited to addressing the issue of upper censoring
but, as previously mentioned, it is not clear that the general framework provided by
this approach has been fully exploited to date. A general problem with modelling
of EQ-5D utility values to date is that the t of the models is poor at the extremes
of the distribution. Specically, models tend to underpredict at the upper extreme
of the EQ-5D scale and overpredict over much of the remainder of the scale but
particularly at the lower end, Brazier et al. (2009), Rowen et al. (2009). Therefore,
as Crott and Briggs (2010) note, there is currently no agreement of the best method
to use. Studies have not applied the same criteria for judging the appopriateness of
models and there are di¤erences in the characteristics of the datasets used in these
studies that may inuence the ndings.
3 Data and Methods
3.1 The Rheumatoid Arthritis dataset
Rheumatoid Arthritis (RA) is the most common form of inammatory arthritis
with prevalence estimated at 0.8% of the population, Symmons et al. (2002), and
incidence between 1.5 per 10,000 for males and 3.6 per 10,000 for females in the
UK, Cooper (2000). In recent years, treatment of this condition has been vastly
altered by the development of so-called biologic drugs. Whilst proven to be clin-
ically e¢ cacious, their relatively high cost make them obvious candidates for cost
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e¤ectiveness analyses. Thus, there has been an explosion in the number of such
studies undertaken in this eld.
Almost all these economic evaluations are based on models which dene health
states or proles in terms of the Health Assessment Questionnaire Disability Index
(HAQ) (NICE (2009), Wailoo et al. (2008), Chen et al (2006), Kobelt et al. (2002)).
This is a validated clinical outcome measure that focuses on the functional capacity
of a patient and there is a de facto mandatory requirement for its inclusion in RA
clinical trials, Aletaha et al. (2008). The HAQ covers 8 categories of functioning
(dressing, rising, eating, walking, hygiene, reach, grip, and usual activities) and is
scored from 0 (no disability) to 3 (completely disabled) in steps of 0.125, although
the scale is generally treated as fully continuous. Since preference based measures
of outcome that would allow direct modelling of QALYs were not included in many
of the clinical trials in this area, nor in the studies that inform methods of extrapo-
lation beyond the trials, it becomes necessary to statistically model the relationship
between HAQ and a preference based measure of health related quality of life in
order to estimate QALYs.
A number of such models have been reported, many of which are used in economic
evaluations. These cover a range of preference based instruments including EQ-5D
(Bansback et al. (2009), Hawthorne et al. (2000), Hurst et al. (1997), Lindgren et
al (2009), Marra et al. (2007), Wailoo et al. (2008)), SF6D (Bansback et al. (2009),
Marra et al. (2007),Wailoo et al. (2008)), HUI2 and HUI3 (Bansback et al. (2005),
Marra et al. (2007)). Almost all are simple linear regression models. In general
these studies only consider HAQ as a covariate, although some studies include age
(Marra et al. (2007), Wailoo et al. (2008)), gender (Bansback et al. (2005), Wailoo
et al. (2008), Lindgren et al (2009)), or other clinical measures such as pain (Hurst
et al. (1997)), disease activity (Hurst et al. (1997), Lindgren et al (2009)), or disease
duration (Wailoo et al. (2008)).
Most consider only a linear relationship between HAQ and health utility. Malottki
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Figure 2: Histogram of EQ-5D from patients with rheumatoid arthritis used in
current study
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et al. (2009) include a quadratic term for HAQ making the relationship to EQ-5D
non-linear. Wailoo et al. (2008) use a non linear regression with logistic function
to constrain the predicted values of the feasible range of the EQ-5D/SF6D instru-
ments. Bansback et al. (2009) models the individual domains of HAQ as explanatory
variables rather than the HAQ summary measure and is therefore a quite di¤erent
approach to the other publications.
Here we use a new, rich dataset to estimate the relationship between EQ-5D and
HAQ as well as other relevant explanatory variables. The data come from the Com-
bination Anti-Rheumatic Drugs in Early Rheumatoid Arthritis (CARDERA) Trial
(Choy et al. (2008)) comprising 467 patients randomised to receive four di¤erent
drug treatment strategies. Patient outcomes were assessed at baseline, 6, 12, 18 and
24 months.
Whilst this was a patient population with recently (within 2 years) diagnosed
RA, the spread of patients across the entire feasible ranges of both HAQ and EQ-5D
make this a dataset well suited for the current problem. As is typical with most
studies, particularly clinical trials which tend to recruit relatively healthier patients
than in clinical practice, there is a relative paucity of observations at the most
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extreme level of functional limitation, that is a HAQ score of 3.
The data shown in Figure 2 clearly demonstrate the typical pattern in EQ-5D
data. There is a mass point at 1 (full health) and a clear gap until the next set of
values. There are at least two other groupings one between 0.5 and 0.85 which
has a left skew and another centred around zero. The data span the entire range of
feasible EQ-5D values.
3.2 Models
We estimated models within four broad classes.
Model 1: Random e¤ects linear regression. We use a standard linear
regression with random coe¢ cients to reect the fact that each patient provides
values at several timepoints during the study. The estimated model for yit (EQ-5D
for individual i -level 2 or between level units, and time period t - level 1 or within
level units) can be written as:
yit = x
0
iti + "it
ki = z
0
ik + uki
where i is a (k  1) vector of random coe¢ cients ki, x0it is a row vector of level
1 covariates, z
0
i is a row vector of level 2 covariates, "it is IID N (0; 
2
"), uki is an
element of the (k  1) vector uk which is N (0;
) and "it is independent of all the
uki. In principle, this general specication allows all the coe¢ cients in the vector i
to be random. The majority of applications where a random e¤ects linear regression
model is used allow only the intercept to vary randomly.
Model 2: Random e¤ects Tobit model. The linear regression assumption
is problematic because it implies that values outside the EQ-5D lower and upper
boundaries can be generated by the model. The Tobit model takes into account
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not only that our dependent variable is censored at one but also that there may be
a substantial concentration of observations at the censored point (full health)1. A
latent variable, yit; is dened with a conditional normal distribution. This latent
variable is articially censored at one in our case, turning the usual regression model
into a model with a discrete element at the censored point and a continuous model
elsewhere. The top panel of Figure 3 shows the di¤erences between the distributions
implied by the linear regression and the Tobit models and how the Tobit model is
able to generate a concentration of observations at the tail of the distribution. This
is essentially an ad hoc modication of the previous linear regression model 1 in
order to account for these features. In many applications, the latent variable yit
is given some meaning. For example, when modelling the number of hours worked
using a Tobit model, the latent variable is often thought of as the "desired hours of
work" which may be negative. However, the derivation of the original Tobit model
(Tobin, 1958) does not require any interpretation of the latent variable. The random
e¤ects Tobit model can be written as:
yit = min fyit; 1g
yit = x
0
iti + "it
ki = z
0
ik + uki
Model 3: Random e¤ects Adjusted Censored Model (ACM). Another
key feature of EQ-5D data is that it is not feasible to generate values between 0.833
and 1. The EQ-5D instrument is relatively crude and may be insu¢ ciently sensitive
to detect minor departures from full health. Departures from full health are scored
as equivalent to full health unless they are su¢ cient to reduce patient quality of
life on at least one of the ve dimensions in the EQ-5D instrument. Therefore, the
1It does not deal with the lower limiting value although it can easily be modied to do so. In
our dataset, we have very few observations at the bottom end of the distribution so we make no
attempt to deal with this issue.
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standard Tobit model is not su¢ cient since it deals with the upper censoring but
not with the gap between one and the next feasible value. We modify the Tobit
model so that the concentration of observations at 1 is accompanied by a gap to the
next set of observations at 0.883. The peak at 1 is therefore comprised both of the
gap to the left and the censoring to the right. the model can be written as follows:
yit =
8><>: 1 if y

it > 0:883
yit otherwise
yit = x
0
iti + "it
ki = z
0
ik + uki
An example of a distribution generated by this type of model can be seen in the
lower panel of Figure 3.
Model 4: Random e¤ects Adjusted CensoredMixtureModel (ACMM).
The last feature of the EQ-5D data that none of the previous models deal with is the
multi-modality of the distribution and possible departures from normality across the
rest of the distribution. This feature can be the result of unobserved heterogeneity
in the form of latent classes. Intuitively, the population may be made up of several
groups, or "latent classes", with potentially di¤erent relationships to the depen-
dent variable. These models can be estimated by using mixtures (McLachlan and
Peel (2000)). Mixtures are very exible and can well accommodate the statistical
challenges posed by typical EQ-5D distributions.
Conditional on an observation belonging to class Cit; the model becomes:
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yitjCit =
8><>: 1 if y

itjCit > 0:883
yitjCit otherwise
yitjCit = x
0
itic + "itc
kic = z
0
ikc + uki
We assume a multinomial logit model for the probability of latent class member-
ship:
P (Cit = cjwit) = exp (w
0
itc)PP
s=1 exp (w
0
its)
where w0it is a vector of variables that a¤ect the probability of class membership, c
is the vector of corresponding coe¢ cients and P is the number of classes. Note that
it is possible when estimating this model (and also a general latent class model)
to nd that the mean of one of the classes is one, irrespective of the values of the
covariates, and its variance tends to zero. In this case, if the optimal number of
classes is two, the resultant model is analogous to the two part or hurdle model.
Whilst we apply adjusted censored normal distributions for each of the latent
classes, as the mean of the distribution moves away from the censoring point and/or
the variance decreases, so the distribution tends to that of the normal.
Some judgment must be used in determining the appropriate number of latent
classes since the usual likelihood ratio test cannot be used to test nested latent class
models. Some of the parameters (the variances of the latent classes) are on the
boundary of the parameter space which distorts the distribution of the statistic and
thus the usual test cannot be applied. The Bayesian Information Criteria (BIC) is a
recommended, good indicator of the appropriate number of classes as well as plots of
the likelihood values for models with di¤erent classes to identify a attening of the
likelihood values. This indicates where the addition of further latent classes does not
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improve the likelihood substantially (Nylund et al. (2007)). It is worth noting that
as the number of classes is increased, the model can be viewed as semiparametric,
a midpoint between a fully parametric model with a single latent class (or mixture
component) and a nonparametric model in the case where the number of components
equals the sample size. If the aim is to achieve the best t possible, increasing the
number of classes based only on BIC for example might be a good idea although in
this case the classes might loose their meaning. If the aim is however to t a model
where the classes have a substantive meaning so that it can be used for out of sample
predictions then a compromise between the BIC and consideration of the size and
di¤erences between the latent classes is needed to prevent the inclusion of latent
classes with a very small size including perhaps only a small number of outliers.
Figure 3 compares an example distribution generated by this model to models 1 to
3.
All these models can be estimated using maximum likelihood. Robust standard
errors using a sandwich estimator are used for all the models to protect against
non-normality. All analyses were undertaken using the Mplus programme, Muthén
and Muthén (2008), except for those based on adjusted censored models which
were programmed in GAUSS, GAUSS (2008). The problems of estimating mixture
models are well documented in the literature due to multiple optima of the likelihood
function. Using only one run of the usual local optimisation algorithms typically
leads to nding only a local maximum. To overcome this problem, Mplus uses a large
set of random starting values for a few iterations of an Expectation Maximisation
algorithm before selecting a few promising values to optimise fully. The parameter
values that achieve the highest likelihood are then selected as the global maximum.
For the adjusted censored models we used a global optimisation algorithm, simulated
annealing (Corana (1987); Go¤e et al. (1994)) to obtain a starting value near the
nal solution. A stopping rule was applied to ensure that the function was in the
vicinity of a global maximum. We then switched to a local maximisation algorithm
15
for the nal optimisation stages (see Hernández Alava (2002) for the rst application
of simulated annealing to the optimisation of mixture models that we are aware of).
Scripts of the codes and details of results for all models that were run are available
from the authors on request.
There is a tendency for models to be compared in terms of their goodness of
t. Typically R2 or adjusted R2 are used but there are various other measures of
errorthat are widely reported and are used to choose between models, for exam-
ple, the Mean Error (ME), Mean Absolute Error (MAE) and Root Mean Squared
Error (RMSE). Such summary measures provide an indication of the magnitude of
the di¤erence between the observed and predicted values but are of limited value
for model comparisons (see Charemza and Deadman (1992) for a discussion of the
dangers of using R2=R¯2). Particularly in the situation where we wish to use such es-
timates in decision models that cover a large spectrum of disease, that is, predicting
across a wide EQ-5D range, it is essential that no systematic bias is introduced and
that predictions lie in the feasible range. Summary measures of model prediction
do not provide a basis for choosing between models in this situation.
In what follows, we compare models using a range of plots and criteria. Model t
is described using penalised likelihood criteria (Akaike Information Criteria (AIC)
and BIC).
4 Results
We initially compared linear and Tobit models using only HAQ and patient demo-
graphic variables age and sex (age is centred at its sample mean and measured in
ten year units). We found that the inclusion of HAQ2, thereby allowing a non linear
relationship with EQ-5D was warranted. Similarly, the inclusion of age2 improved
the models. In all models we found a positive association between EQ-5D and age,
conditional on HAQ. This is consistent with previous literature both in RA (Marra
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Figure 3: Illustrative histograms of possible model distributions
0
1
2
3
4
D
en
si
ty
.4 .6 .8 1 1.2
Linear regression model
0
1
2
3
4
D
en
si
ty
.4 .6 .8 1
Tobit model
0
1
2
3
4
D
en
si
ty
.2 .4 .6 .8 1
Adjusted censored model
0
1
2
3
D
en
si
ty
-1 -.5 0 .5 1
Adjusted censored mixture model
et al. (2007), Wailoo et al. (2008)) and other conditions (see for example Goldsmith
et al. (2010)). We included the follow up times as separate covariates to test for
any e¤ect of disease duration but these were grossly insignicant and not retained
in any of the models. The preferred models are a random e¤ects linear regression
and a Tobit model with two independent random e¤ects for the intercept and the
coe¢ cient of HAQ. In identifying the preferred specication of the models, we con-
sidered a range of options. These included a standard Tobit with no random e¤ects,
one, two and three random e¤ects (for the intercept and the coe¢ cients of HAQ
and HAQ2), both considered as either independent or correlated, and the inclusion
of an ination factor for the censoring point. The preferred Tobit specication in-
cludes two independent random e¤ects and achieved the lowest information criteria
compared to the alternative Tobit specications. The linear regression has a lower
AIC (-624.0 vs 32.1) and BIC (-579.2 vs 99.4) than the Tobit model. This is due to
the fact that the observations include a substantial peak at EQ-5D scores of about
0.5, thereby pulling down the estimates for the linear regression and causing the
observations around one to have less inuence. Importantly, within the sample the
linear regression does not predict values exceeding unity.
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The inclusion of pain measured on a Visual Analogue Scale (VAS) vastly im-
proved the models, results for which are shown in Table 1. Pain is one of the most
heavily weighted items in the EQ-5D valuation regression but does not feature in the
HAQ summary score. Previous studies focus on function but the trial data provided
an opportunity to include this missing dimension of quality of life in the analysis.
For the linear regression the AIC reduced to -1058.2 and the BIC reduced to -1007.7.
With the inclusion of pain, the preferred specication of the Tobit model required
only one random e¤ect, a random intercept. The AIC reduced to -345.6 and the
BIC reduced to -295.1. Thus, the apparent heterogeneity in the coe¢ cient of HAQ
may be explained by the omission of the pain covariate. The linear regression still
outperforms the Tobit model in terms of model t. In addition to AIC and BIC,
the ME, MAE and RMSE are approximately equivalent on the utility scale. How-
ever, there are other aspects of the performance of the linear regression that warrant
consideration. Most importantly, the predicted values can exceed one. Within the
current sample this is not the case, as with the models excluding pain, but when
predicting out of sample, unfeasible predictions will be generated. Furthermore, the
predicted values from the linear regression do not reect the characteristics of the
underlying data in other ways. In particular, the mass of observations at one but
also the gaps and multi-modality of the distribution are not well reected by this
model as demonstrated in Figure 4 by the histogram of the predicted values.
The RE Tobit model addresses the issue of censoring and Figure 4 illustrates that
there is a resultant peak in values close to one. The RE adjusted censored model
develops this further to address the gap between full health and all intermediate
health states. Table 1 shows that model t, measured by the information crite-
ria, is improved substantially compared to the unadjusted RE Tobit model. More
importantly, the distribution of predicted values illustrate that the model captures
the key feature of the data at the top of the distribution. The di¤erence is slight
when considering the predicted values but there is a more pronounced rise in the
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density at higher values of HAQ. Note however that the distribution of expected
values will not itself demonstrate the peak at one with the subsequent gap since this
plot smooths out such peaks. This is a feature of the underlying adjusted censored
model, not the resultant expected values. The predicted values are averages across
individuals so although no individual will have a value between 1 and 0.883, the
predicted values can lie in this range.
We considered a variety of mixture models. The models varied in terms of the
underlying distributions that comprised the mixture. We considered mixtures of
normal, Tobit and adjusted censored models. It was considered that the models
that included three latent classes were preferred. We chose three latent classes
considering mainly the BIC balanced against consideration of the size of the latent
classes. There is a danger in the inclusion of an excessive number of latent classes
where a class may include only a small number of outliers. This phenomenon is
clearly observed when we move from a model with three latent classes to a model
with four. The model for the four latent classes essentially splits one of the latent
classes of the three class model, the class at the highest levels of HAQ. One of these
two classes is quite substantial in size but the other class is not. In fact we nd that
only 13 observations out of the 2003 in our sample are most likely to be in this class.
In addition, the increase in the likelihood value is not as substantial as when the
classes are increased from two to three also signalling that this latent class is not
substantial enough and might just contain a few outliers. Initially the model with
three latent classes contained a HAQ2 term in all the classes. However, it was found
that the estimated coe¢ cients for HAQ and HAQ2 in latent class 1 were insignicant
but very highly correlated and therefore only a linear term was needed in this class.
Table 2 demonstrates that this further development produces a model that vastly
outperforms the non mixture models. The information criteria are both substantially
lower than the other models. The average errors are smaller on all measures and,
although the scale of EQ-5D can mask these di¤erences, we see an approximate 4%
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improvement in MAE and 1% in RMSE compared to the standard RE linear model.
The model identies three separate latent classes which demonstrate di¤erent
relationships between EQ-5D, function and pain. Table 3 shows the summary char-
acteristics of the observations when grouped by the latent class with the most prob-
able membership. The groups are clearly di¤erent in terms of functional disability
and pain. Class 1 has a mean HAQ of 2.26 indicating substantial disability, and
a high pain score mean of 72.1. This reects the element of the data distribution
at the bottom of the EQ-5D scale. Class 2 has the least disability as measured by
HAQ and the least amount of pain. The third class has moderate pain (mean 33.3)
and functional disability (mean 1.24 HAQ). Classes 2 and 3 are both required in
order to reect the concentration of observations at one and the peak in the skewed
distribution below this. It is the mixture of two latent classes with di¤erent means
and variances that reproduces this skew.
Table 2 shows that for latent class 1, only a linear term on HAQ is needed and the
coe¢ cient for pain is both large and signicant. Latent class 2 has a non signicant
coe¢ cient for pain. Both HAQ and HAQ2 are signicant and relatively large, the
latter negatively so. This results in a U - shaped relationship between HAQ and the
latent variable, where the latter is predicted to increase once the HAQ functional
ability deteriorates beyond around 2. The reason for this is that the model is trying
to incorporate the small number of outliers that occur at the highest HAQ value
where we see very few observations. For the third latent class, both HAQ and pain
covariates are signicant. The quadratic HAQ coe¢ cients result in a deterioration
in the latent variable as function decreases, but at a decreasing rate within the
feasible range. The size of the coe¢ cients and their implications cannot be judged
directly since this is a highly nonlinear model. Table 4 presents examples of the
predicted values for selected combinations of covariates. For a female of average age
in the sample and both HAQ and pain of zero the predicted EQ-5D is 0.94. We see
that the expected values for each class range from 0.34 for class 1 to 0.98 for class
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2. The predicted probabilities of latent class membership are very di¤erent. This
individual has a zero probability of being in class 1 and a high predicted probability
(0.77) of being in class 2, the class with the highest expected EQ-5D value. Thus the
predicted EQ-5D value lies in between that of class 2 and class 3. As pain increases,
the predicted EQ-5D value goes down, but the relationship is not linear (unlike the
linear regression model which implies that a change in pain will always lead to the
same change in the predicted EQ-5D regardles of the levels of pain). The expected
values for each of the classes decrease and the probabilities change dramatically.
When pain is very high (93) the probability of class 3 membership is 0.91. Also as
HAQ increases, we see a decrease in the predicted EQ-5D. The impact of gender is
relatively small and varies in magnitude depending on the values of other covariates.
Males have consistently lower predicted values of EQ-5D. The di¤erences are much
smaller than the linear regression which estimates a constant di¤erence of 0.05.
The improvement in model t gained from the mixture model approach is very
noticeable at the lower end of the HAQ scale, that is, where patients have the
least functional disability. A recognised issue in modelling health utility data arises
in the relatively poor model t at the extremes of the health prole. Figure 5
illustrates that the mixture model ts extremely well between HAQ scores of 0 to
1, unlike all the other non-mixture models which underpredict at HAQ of 0 (no
functional disability) and systematically overpredict at HAQ scores between 0.3 and
1. Interestingly, we found that a mixture of normal distributions (not reported here)
consistently underpredicts at HAQ between 0.15 and 0.9 suggesting that it is the
combination of mixture modelling and the ACM that is required. Table 5 presents
the mean error, MAE and RMSE of all the models at three di¤erent intervals of
HAQ. The ACMM always outperforms the other models in terms of mean error
and MAE. It also outperforms the other models in terms of RMSE between HAQ
scores of 0 to 1 and 1 to 2. The RMSE of the ACMM is only worse between HAQ
scores of 2 to 3. Further investigation identied that this lower predictive ability of
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Figure 4: Histograms of predicted values
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the RE ACMM, as judged by the RMSE, is only for the last 3 HAQ scores - 2.75.
2.875 and 3. At these levels of functional disability the dataset has an extremely
low number of observations which appear very di¤erent and may be outliers. Up to
and including a HAQ score of 2.625, the ACMM still outperforms the linear model
with a RMSE for the interval (2-2.625) of 0.2425 compared to a RMSE for the linear
model of 0.2427. The ACMM is more exible than the other models and is therefore
sensitive to these extreme observations at the tails of the distribution.
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Figure 5: Observed and predicted mean EQ-5D by HAQ (0 to1)
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Table 1: Parameter estimates (se) for linear, Tobit and adjusted censored models
of EQ-5D
RE Linear Model RE Tobit RE Adjusted
Censored Model
Within HAQ  0:084
(0:020)
 0:165
(0:025)
 0:115
(0:023)
level HAQ2  0:045
(0:008)
 0:022
(0:009)
 0:036
(0:009)
Vaspain/100  0:478
(0:027)
 0:499
(0:028)
 0:484
(0:028)
2" 0:028
(0:001)
0:032
(0:002)
0:030
(0:002)
Between Intercept 0:941
(0:012)
1:013
(0:017)
0:967
(0:015)
level Age-54:32
10
0:019
(0:005)
0:018
(0:005)
0:019
(0:005)
Age-54:32
10
2
0:005
(0:003)
0:007
(0:003)
0:006
(0:003)
Male  0:046
(0:013)
 0:047
(0:014)
 0:047
(0:014)
2u 0:010
(0:002)
0:012
(0:002)
0:011
(0:002)
AIC  1058:17  345:55  558:84
BIC  1007:75  295:13  508:42
ME (sd) 0:0003(0:194)  0:0001(0:193) 0:0005(0:194)
MAE (sd) 0:1505(0:122) 0:1508(0:121) 0:1508(0:121)
RMSE 0:1935 0:1934 0:1935
AIC - Akaike In formation Criteria , B IC - Bayesian In formation Criteria ,
ME - M ean Error, MAE - M ean Absolute Error, RMSE- Root M ean Squared Error
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Table 2: Parameter estimates (se) for ACMM model of EQ-5D
Within Latent class 1 HAQ  0:062
(0:015)
level HAQ2  
( )
VASpain/100  0:295
(0:030)
2"1 0:015(0:002)
Latent class 2 HAQ  0:245
(0:044)
HAQ2 0:068
(0:019)
VASpain/100  0:105
(0:134)
2"2 0:006(0:001)
Latent class 3 HAQ  0:160
(0:013)
HAQ2 0:025
(0:005)
VASpain/100  0:056
(0:018)
2"3 0:003(:000)
Between Latent class 1 Intercept 0:343
(0:037)
level Latent class 2 Intercept 0:990
(:025)
Latent class 3 Intercept 0:806
(0:011)
All classes Age-54:32
10
0:007
(0:002)
Age-54:32
10
2
0:004
(0:001)
Male  0:012
(0:006)
2u 0:002
(0:000)
Within Latent class 1 Intercept  5:201
(0:423)
level HAQ 2:868
(0:178)
categorical VASpain/100 5:179
(0:433)
latent Latent class 2 Intercept 2:203
(0:312)
variables HAQ 0:485
(0:214)
VASpain/100  11:366
(4:227)
AIC  2051:11
BIC  1911:05
ME (sd)  0:0003 (0:192)
MAE (sd) [% improvement] 0:1438 (0:128) [4%]
RMSE [% improvement] 0:1923 [1%]
AIC - Akaike In formation Criteria , B IC - Bayesian In formation Criteria ,
ME - M ean Error, MAE - M ean Absolute Error, RMSE- Root M ean Squared Error
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Table 3: Patient characteristics by most
likely latent class (std. dev.)
Variable Class 1 Class 2 Class 3
HAQ 2:26(0:35) 0:37(0:46) 1:24(0:60)
VASpain 72:1(14:6) 3:0(2:5) 33:3(19:6)
Age (yrs) 54:5(12:4) 53:8(11:8) 54:2(12:6)
Male 0:25(0:44) 0:39(0:49) 0:32(0:46)
Table 4: Predicted EQ-5D values for the RE ACMM.
Male, age 54
HAQ VASpain dEQ5D dEQ5D1 dEQ5D2 dEQ5D2 P1 P2 P3
0 0 0.9430 0.3426 0.9814 0.8165 0.0005 0.7687 0.2308
0 52 0.7724 0.1890 0.9520 0.7818 0.0174 0.0052 0.9773
0 93 0.6942 0.0679 0.9153 0.7561 0.0899 0.0000 0.9100
1 0 0.7716 0.2806 0.8257 0.6704 0.0044 0.6626 0.3331
1 52 0.5884 0.1270 0.7633 0.6410 0.1032 0.0029 0.8940
1 93 0.3790 0.0058 0.7168 0.6179 0.3903 0.0000 0.6097
2 0 0.6711 0.2185 0.7760 0.5848 0.0374 0.5227 0.4399
2 52 0.3461 0.0649 0.7166 0.5555 0.4272 0.0011 0.5717
2 93 0.0582 -0.0562 0.6721 0.5324 0.8057 0.0000 0.1943
2.5 0 0.6299 0.1875 0.8094 0.5607 0.1014 0.4302 0.4684
2.5 52 0.2056 0.0339 0.7479 0.5314 0.6551 0.0005 0.3444
2.5 93 -0.0357 -0.0872 0.7022 0.5083 0.9134 0.0000 0.0866
Female, age 54
HAQ VASpain dEQ5D dEQ5D1 dEQ5D2 dEQ5D2 P1 P2 P3
0 0 0.9360 0.3307 0.9766 0.8021 0.0005 0.7687 0.2308
0 52 0.7590 0.1771 0.9430 0.7683 0.0174 0.0052 0.9773
0 93 0.6814 0.0560 0.9033 0.7432 0.0899 0.0000 0.9100
1 0 0.7583 0.2686 0.8118 0.6584 0.0044 0.6626 0.3331
1 52 0.5764 0.1150 0.7502 0.6291 0.1032 0.0029 0.8940
1 93 0.3671 -0.0061 0.7043 0.6060 0.3903 0.0000 0.6097
2 0 0.6584 0.2066 0.7627 0.5729 0.0374 0.5227 0.4399
2 52 0.3342 0.0530 0.7041 0.5436 0.4272 0.0011 0.5717
2 93 0.0463 -0.0681 0.6600 0.5205 0.8057 0.0000 0.1943
2.5 0 0.6171 0.1756 0.7957 0.5488 0.1014 0.4302 0.4684
2.5 52 0.1937 0.0220 0.7350 0.5195 0.6551 0.0005 0.3444
2.5 93 -0.0476 -0.0991 0.6898 0.4964 0.9134 0.0000 0.0866
dEQ5D predicted EQ-5D, dEQ5Dspredicted EQ-5D for class s
Ps probability of class s membership
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Table 5: Measures of accuracy of predictions by HAQ interval.
HAQ scores [0, 1] (n = 758)
RE linear model RE Tobit RE ACM RE ACMM
ME -0.0055 -0.0113 -0.0053 -0.0025
MAE 0.1032 0.1034 0.1038 0.0955
RMSE 0.1366 0.1363 0.1367 0.1328
HAQ scores (1,2] (n = 891)
RE linear model RE Tobit RE ACM RE ACM
ME 0.0040 0.0089 0.0048 0.0019
MAE 0.1670 0.1675 0.1671 0.1603
RMSE 0.2109 0.2108 0.2109 0.2096
HAQ scores (2,3] (n = 354)
RE linear model RE Tobit RE ACM RE ACM
ME 0.0032 0.0011 0.0022 -0.0012
MAE 0.2101 0.2102 0.2102 0.2057
RMSE 0.2447 0.2449 0.2447 0.2467
ME - Mean Error, MAE - M ean Absolute Error, RMSE- Root M ean Squared Error
5 Discussion
Health related quality of life data typically exhibit distributional properties that
raise numerous statistical challenges. In some respects these are more complex than
those that arise in relation to healthcare costs, where there has been substantial
attention given to the development and application of exible statistical models to
deal with issues such as repeated measures, skewness and left censoring (Hernández
Alava and Wailoo (2010)).
Whilst standard models and methods for dealing with censoring have been ap-
plied when modelling health state utilities, these o¤er only limited and partial so-
lutions to these challenges. A common feature arising from the limitations of such
models is poor t at the extremes of the distribution. The commonly used Tobit and
other censored regression models o¤er a method for dealing with the upper bound
of full health in health utility data. We have developed a censored regression model
that provides a more appropriate method to reect the gap between full health and
intermediate health states, a particular feature that results from the approach used
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to generate the EQ-5D tari¤. Only limited consideration has been given to the use
of latent class mixture models in this eld to date. The small number of studies that
have considered the approach have focussed on the issue of ceiling e¤ects, Huang et
al. (2008), Pullenayegum et al. (2010).
When considering measures of model t we use penalised likelihood measures.
When we compared the models using data from a clinical trial of patients with
rheumatoid arthritis, we found that the linear regression outperforms either of the
censored regression models. This is because our dataset exhibits a relatively large
peak of observations around an EQ-5D value of 0.5. This pulls the estimates from
the linear regression down and diminishes the importance of the values at high
EQ-5D scores, where di¤erences betwen the EQ-5D and censored models will be
more profound. The linear regression does not predict unfeasible values within the
observed dataset but may do so in a di¤erent sample where patients exhibit di¤erent
characteristics to those included in this trial. This is of critical importance when
considering the intended use of such models in cost e¤ectiveness analyses. Here it is
typical to simulate patients with varying characteristics and over long time periods.
These models can be expected to cover a wide range of functional disability, pain and
other relevant patient characteristics such that it is likely that implausible predicted
values will be generated. In this situation the analyst may need to articially censor
the predicted values themselves. Thus, there are clear dangers with a reliance on
model t alone in model selection in this situation. The adjusted censored model
improves both model t and provides a more faithful reection of the underlying
data compared to standard censored models such as the Tobit model.
This paper develops the approach further by employing mixture models. Mixture
models o¤er a highly exible tool that can be used to deal with the remaining
distributional challenges. Each of the mixture models we considered o¤ered vastly
superior performance compared to standard linear regression and censored regression
models. In particular, we demonstrate that this model predicts accurately at the
27
highest EQ-5D and maintains this high degree of predictive accuracy across the EQ-
5D range. Only where data is sparse does this accuracy decrease. This is the rst
application of censored mixture models in this area that we are aware of.
Our preferred model specication identies three latent classes clearly distin-
guished by the relative role of functional disability and pain in determining EQ-5D
utility values. The model is formed as a mixture of adjusted censored distributions.
Our ndings also have specic implications for cost e¤ectiveness modelling of
interventions in rheumatoid arthritis. First, it is clear that estimates of health state
utilities are improved by the inclusion of pain and other patient level covariates
rather than functional ability alone. Since pain is not a feature of the HAQ score
but is a heavily weighted component of the EQ-5D tari¤ the nding is perhaps not
surprising. Standard composite outcome measures used in RA clinical trials and ob-
servational datsets, such as the American College of Rheumatology (ACR) response
criteria, include VAS pain as one of the components. Where treatment e¤ects are ob-
served on pain as well as function, appropriate statistical models to estimate health
state utilities become critical to avoid biased estimates of cost e¤ectiveness. In order
for researchers to make use of the estimates in the proposed mixture models and the
associated uncertainty, the full variance covariance matrix is available from the fol-
lowing website (www.she¢ eld.ac.uk/scharr/sections/heds/dps-2010.html) and the
expression for the predicted values in the appendix.
There are several potential limitations. The approach treats the values from the
EQ-5D tari¤ as if they were data rather than estimates. The uncertainty in the
original regression work reported by Dolan et al. (1995) is ignored. Furthermore,
the challenges that arise from the distributional characteristics of the EQ-5D tari¤
may be avoidable. The method by which EQ-5D values are generated is based
on simple linear regression model that itself does not perform well and does not
apply a consistent approach to the values assigned to full health versus all other
intermediate health states. The application of more exible models to generate
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the EQ-5D tari¤ may result in less statistical challenges for analysts that need to
estimate the relationship with clinical and sociodemographic variables. We note
that health state utilities generated from the EQ-5D in di¤erent populations exhibit
the same distributional features as the data presented here, see for example Huang
et al. (2008). Nevertheless, there may also be value in examining the performance
of the mixture of adjusted censored features of distributions for health utility data
generated from instruments other than the EQ-5D.
The dataset on which the analyses are based is from a group of patients with
early RA at the point of entry to the study. Despite the fact that the estimates span
two years of follow up and we found no evidence of a time trend, it may be the case
that patients with more established disease do not exhibit the same relationships
between EQ-5D, pain and function. For example, there may be a greater degree of
adaptation to functional decline in later disease that is reected to a greater degree
in HAQ than EQ-5D. In addition, the dataset includes few observations at the
most extreme level of functional disability, with outliers perhaps exerting a strong
inuence on the model. Therefore, further renement of the ACMM in an additional
dataset of established disease may be useful.
In summary, it is clear that the mixture modelling approach provides a general
framework which can reect the specic distributional characteristics of health utility
data. When combined with the adjusted censored distribution it is possible to obtain
a exible model that vastly outperforms standard linear regression and censored
regression approaches.
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Appendix
EQ-5D predictions using the random e¤ects ACMM.
This appendix derives the expression for the prediction of EQ-5D using the
ACMM model with a random intercept. Conditional on an observation belonging
to class Cit; the random e¤ects ACMM model can be written as:
yitjCit =

1 if yitjCit > 0:883
yitjCit otherwise
yitjCit = x
0
itic + "itc
1ic = z
0
ic + ui
where i is a (k  1) vector of coe¢ cients ki, x0it is a row vector of level 1
covariates, z
0
i is a row vector of level 2 covariates, "it is IID N (0; 
2
"), ui is IID
N (0; 2u) and "it is independent of ui. A multinomial logit model for the probability
of latent class membership is assumed as follows:
P (Cit = cjwit) = exp (w
0
itc)PP
s=1 exp (w
0
its)
where w0it is a vector of variables that a¤ect the probability of class membership, c
is the vector of corresponding coe¢ cients and P is the number of classes (P = 3 in
the nal model used in our analysis).
The EQ-5D prediction based on this model, E
 
yitjx0it; z0i; w0ij

, is calculated using
the following expression:
E

yitjx0it; z
0
i; w
0
ij

= Eui
h
E

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i; ui
i
=
1Z
 1
1
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
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
dui
where  (:) is the standard normal density function and
E

yitjx0it; z
0
i; w
0
ij; ui

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CX
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exp
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w0ijc
PC
s=1 exp
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w0ijs
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
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
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In the last equation  (:) is the standard cumulative normal and 	 = 0:883.
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